nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—DRD5—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0639	0.0697	CbGpPWpGaD
Rotigotine—ADRA2B—Platelet Aggregation (Plug Formation)—GP5—cervical cancer	0.0542	0.0591	CbGpPWpGaD
Rotigotine—DRD4—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0471	0.0514	CbGpPWpGaD
Rotigotine—DRD1—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0424	0.0463	CbGpPWpGaD
Rotigotine—DRD3—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0419	0.0457	CbGpPWpGaD
Rotigotine—ADRA2B—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0378	0.0413	CbGpPWpGaD
Rotigotine—HTR1A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0365	0.0398	CbGpPWpGaD
Rotigotine—DRD2—Amine ligand-binding receptors—TAAR6—cervical cancer	0.032	0.035	CbGpPWpGaD
Rotigotine—DRD5—G alpha (s) signalling events—TAAR6—cervical cancer	0.0264	0.0288	CbGpPWpGaD
Rotigotine—DRD1—G alpha (s) signalling events—TAAR6—cervical cancer	0.0175	0.0191	CbGpPWpGaD
Rotigotine—ADRA2B—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.0148	0.0162	CbGpPWpGaD
Rotigotine—ADRA2B—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.013	0.0141	CbGpPWpGaD
Rotigotine—DRD5—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0126	0.0137	CbGpPWpGaD
Rotigotine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.0115	0.0126	CbGpPWpGaD
Rotigotine—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	0.0111	0.0121	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—UBE3A—cervical cancer	0.0102	0.0111	CbGpPWpGaD
Rotigotine—DRD5—GPCR ligand binding—TAAR6—cervical cancer	0.00957	0.0104	CbGpPWpGaD
Rotigotine—DRD4—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00927	0.0101	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—UBE3A—cervical cancer	0.00915	0.00998	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—UBE3A—cervical cancer	0.00903	0.00985	CbGpPWpGaD
Rotigotine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.0089	0.00971	CbGpPWpGaD
Rotigotine—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.00857	0.00935	CbGpPWpGaD
Rotigotine—DRD1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00835	0.00911	CbGpPWpGaD
Rotigotine—DRD3—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00824	0.00899	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—SERPIND1—cervical cancer	0.00764	0.00834	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—GP6—cervical cancer	0.00764	0.00834	CbGpPWpGaD
Rotigotine—DRD5—GPCR ligand binding—WNT2—cervical cancer	0.00747	0.00815	CbGpPWpGaD
Rotigotine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00744	0.00811	CbGpPWpGaD
Rotigotine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00718	0.00783	CbGpPWpGaD
Rotigotine—DRD4—GPCR ligand binding—TAAR6—cervical cancer	0.00706	0.0077	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—UBE3A—cervical cancer	0.00691	0.00754	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—GP5—cervical cancer	0.00668	0.00729	CbGpPWpGaD
Rotigotine—DRD1—GPCR ligand binding—TAAR6—cervical cancer	0.00636	0.00694	CbGpPWpGaD
Rotigotine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0063	0.00688	CbGpPWpGaD
Rotigotine—DRD3—GPCR ligand binding—TAAR6—cervical cancer	0.00627	0.00684	CbGpPWpGaD
Rotigotine—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	0.00591	0.00645	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—TAAR6—cervical cancer	0.00566	0.00618	CbGpPWpGaD
Rotigotine—DRD5—GPCR ligand binding—WNT5A—cervical cancer	0.00566	0.00618	CbGpPWpGaD
Rotigotine—DRD4—GPCR ligand binding—WNT2—cervical cancer	0.00551	0.00601	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—TAAR6—cervical cancer	0.00547	0.00596	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—TAAR6—cervical cancer	0.00541	0.0059	CbGpPWpGaD
Rotigotine—DRD1—GPCR ligand binding—WNT2—cervical cancer	0.00496	0.00541	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.00492	0.00536	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—TAAR6—cervical cancer	0.00491	0.00536	CbGpPWpGaD
Rotigotine—DRD3—GPCR ligand binding—WNT2—cervical cancer	0.0049	0.00534	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—TAAR6—cervical cancer	0.0048	0.00524	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—WNT2—cervical cancer	0.00442	0.00482	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—WNT2—cervical cancer	0.00427	0.00466	CbGpPWpGaD
Rotigotine—Lethargy—Topotecan—cervical cancer	0.00427	0.051	CcSEcCtD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00427	0.00465	CbGpPWpGaD
Rotigotine—DRD4—GPCR ligand binding—WNT5A—cervical cancer	0.00418	0.00456	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—TAAR6—cervical cancer	0.00399	0.00435	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—WNT2—cervical cancer	0.00383	0.00418	CbGpPWpGaD
Rotigotine—DRD1—GPCR ligand binding—WNT5A—cervical cancer	0.00376	0.0041	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—WNT2—cervical cancer	0.00375	0.00409	CbGpPWpGaD
Rotigotine—DRD3—GPCR ligand binding—WNT5A—cervical cancer	0.00371	0.00405	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—AKAP13—cervical cancer	0.00371	0.00404	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—TAAR6—cervical cancer	0.00362	0.00395	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—TAAR6—cervical cancer	0.00359	0.00392	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—TAAR6—cervical cancer	0.00354	0.00387	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—AKAP13—cervical cancer	0.00336	0.00367	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—WNT5A—cervical cancer	0.00335	0.00366	CbGpPWpGaD
Rotigotine—Weight increased—Topotecan—cervical cancer	0.00329	0.0393	CcSEcCtD
Rotigotine—DRD1—Signaling by GPCR—TAAR6—cervical cancer	0.00326	0.00356	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—WNT5A—cervical cancer	0.00323	0.00353	CbGpPWpGaD
Rotigotine—Infestation—Topotecan—cervical cancer	0.00322	0.0385	CcSEcCtD
Rotigotine—Infestation NOS—Topotecan—cervical cancer	0.00322	0.0385	CcSEcCtD
Rotigotine—DRD3—Signaling by GPCR—TAAR6—cervical cancer	0.00322	0.00351	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—TAAR6—cervical cancer	0.0032	0.00349	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—TAAR6—cervical cancer	0.00309	0.00337	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—TAAR6—cervical cancer	0.00291	0.00317	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—WNT5A—cervical cancer	0.0029	0.00317	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TAAR6—cervical cancer	0.0029	0.00316	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—WNT5A—cervical cancer	0.00284	0.0031	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—WNT2—cervical cancer	0.00283	0.00309	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—TAAR6—cervical cancer	0.00281	0.00306	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—AKAP13—cervical cancer	0.00273	0.00298	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—TAAR6—cervical cancer	0.00271	0.00296	CbGpPWpGaD
Rotigotine—Angiopathy—Topotecan—cervical cancer	0.00262	0.0314	CcSEcCtD
Rotigotine—Immune system disorder—Topotecan—cervical cancer	0.00261	0.0313	CcSEcCtD
Rotigotine—Mediastinal disorder—Topotecan—cervical cancer	0.00261	0.0312	CcSEcCtD
Rotigotine—DRD1—Signaling by GPCR—WNT2—cervical cancer	0.00255	0.00278	CbGpPWpGaD
Rotigotine—Malnutrition—Topotecan—cervical cancer	0.00252	0.0301	CcSEcCtD
Rotigotine—DRD3—Signaling by GPCR—WNT2—cervical cancer	0.00251	0.00274	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—AKAP13—cervical cancer	0.00248	0.00271	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—TAAR6—cervical cancer	0.00246	0.00269	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—AKAP13—cervical cancer	0.00246	0.00269	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—AKAP13—cervical cancer	0.00243	0.00265	CbGpPWpGaD
Rotigotine—Muscle spasms—Topotecan—cervical cancer	0.00242	0.029	CcSEcCtD
Rotigotine—Ill-defined disorder—Topotecan—cervical cancer	0.00234	0.0279	CcSEcCtD
Rotigotine—Angioedema—Topotecan—cervical cancer	0.0023	0.0275	CcSEcCtD
Rotigotine—Malaise—Topotecan—cervical cancer	0.00227	0.0272	CcSEcCtD
Rotigotine—ADRA2B—Signaling by GPCR—WNT2—cervical cancer	0.00227	0.00248	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—WNT2—cervical cancer	0.00226	0.00247	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—AKAP13—cervical cancer	0.00224	0.00244	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00222	0.00242	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—AKAP13—cervical cancer	0.00221	0.00241	CbGpPWpGaD
Rotigotine—Cough—Topotecan—cervical cancer	0.0022	0.0263	CcSEcCtD
Rotigotine—ADRA2B—GPCR downstream signaling—AKAP13—cervical cancer	0.00219	0.00239	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—WNT2—cervical cancer	0.00219	0.00239	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—WNT5A—cervical cancer	0.00214	0.00234	CbGpPWpGaD
Rotigotine—Arthralgia—Topotecan—cervical cancer	0.00214	0.0256	CcSEcCtD
Rotigotine—DRD4—Signaling Pathways—TAAR6—cervical cancer	0.00214	0.00234	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.00214	0.00233	CbGpPWpGaD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00213	0.0255	CcSEcCtD
Rotigotine—Discomfort—Topotecan—cervical cancer	0.00212	0.0253	CcSEcCtD
Rotigotine—HTR1A—GPCR downstream signaling—AKAP13—cervical cancer	0.00212	0.00231	CbGpPWpGaD
Rotigotine—Infection—Topotecan—cervical cancer	0.00204	0.0244	CcSEcCtD
Rotigotine—Nervous system disorder—Topotecan—cervical cancer	0.00202	0.0241	CcSEcCtD
Rotigotine—Skin disorder—Topotecan—cervical cancer	0.002	0.0239	CcSEcCtD
Rotigotine—ADRA2B—Signaling by GPCR—AKAP13—cervical cancer	0.00199	0.00217	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKAP13—cervical cancer	0.00199	0.00217	CbGpPWpGaD
Rotigotine—Hyperhidrosis—Topotecan—cervical cancer	0.00199	0.0238	CcSEcCtD
Rotigotine—Anorexia—Topotecan—cervical cancer	0.00196	0.0234	CcSEcCtD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.00195	0.00213	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.00195	0.00213	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—WNT5A—cervical cancer	0.00193	0.00211	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TAAR6—cervical cancer	0.00193	0.0021	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—WNT2—cervical cancer	0.00192	0.0021	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—AKAP13—cervical cancer	0.00192	0.0021	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—WNT5A—cervical cancer	0.0019	0.00208	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TAAR6—cervical cancer	0.0019	0.00207	CbGpPWpGaD
Rotigotine—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00187	0.0224	CcSEcCtD
Rotigotine—DRD2—GPCR downstream signaling—AKAP13—cervical cancer	0.00186	0.00203	CbGpPWpGaD
Rotigotine—Paraesthesia—Topotecan—cervical cancer	0.00185	0.0221	CcSEcCtD
Rotigotine—Dyspepsia—Topotecan—cervical cancer	0.00181	0.0216	CcSEcCtD
Rotigotine—Decreased appetite—Topotecan—cervical cancer	0.00179	0.0214	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Topotecan—cervical cancer	0.00177	0.0212	CcSEcCtD
Rotigotine—Fatigue—Topotecan—cervical cancer	0.00177	0.0212	CcSEcCtD
Rotigotine—Pain—Topotecan—cervical cancer	0.00176	0.021	CcSEcCtD
Rotigotine—Constipation—Topotecan—cervical cancer	0.00176	0.021	CcSEcCtD
Rotigotine—ADRA2B—Signaling by GPCR—WNT5A—cervical cancer	0.00172	0.00188	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TAAR6—cervical cancer	0.00172	0.00187	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—WNT5A—cervical cancer	0.00172	0.00187	CbGpPWpGaD
Rotigotine—Feeling abnormal—Topotecan—cervical cancer	0.00169	0.0203	CcSEcCtD
Rotigotine—DRD2—Signaling by GPCR—AKAP13—cervical cancer	0.00169	0.00184	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—WNT2—cervical cancer	0.00167	0.00182	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—WNT5A—cervical cancer	0.00166	0.00181	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TAAR6—cervical cancer	0.00166	0.00181	CbGpPWpGaD
Rotigotine—Urticaria—Topotecan—cervical cancer	0.00163	0.0195	CcSEcCtD
Rotigotine—Hypersensitivity—Topotecan—cervical cancer	0.00151	0.0181	CcSEcCtD
Rotigotine—DRD1—Signaling Pathways—WNT2—cervical cancer	0.0015	0.00164	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—TP53—cervical cancer	0.0015	0.00164	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—WNT2—cervical cancer	0.00148	0.00162	CbGpPWpGaD
Rotigotine—Asthenia—Topotecan—cervical cancer	0.00147	0.0176	CcSEcCtD
Rotigotine—DRD4—Signaling Pathways—AKAP13—cervical cancer	0.00147	0.0016	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—WNT5A—cervical cancer	0.00146	0.00159	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TAAR6—cervical cancer	0.00145	0.00159	CbGpPWpGaD
Rotigotine—Pruritus—Topotecan—cervical cancer	0.00145	0.0174	CcSEcCtD
Rotigotine—Diarrhoea—Topotecan—cervical cancer	0.00141	0.0168	CcSEcCtD
Rotigotine—Dizziness—Topotecan—cervical cancer	0.00136	0.0163	CcSEcCtD
Rotigotine—DRD1—Circadian rythm related genes—TP53—cervical cancer	0.00135	0.00147	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—WNT2—cervical cancer	0.00134	0.00146	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—TP53—cervical cancer	0.00133	0.00145	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKAP13—cervical cancer	0.00132	0.00144	CbGpPWpGaD
Rotigotine—Vomiting—Topotecan—cervical cancer	0.00131	0.0156	CcSEcCtD
Rotigotine—DRD3—Signaling Pathways—AKAP13—cervical cancer	0.0013	0.00142	CbGpPWpGaD
Rotigotine—Rash—Topotecan—cervical cancer	0.0013	0.0155	CcSEcCtD
Rotigotine—Dermatitis—Topotecan—cervical cancer	0.00129	0.0155	CcSEcCtD
Rotigotine—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.00129	0.00141	CbGpPWpGaD
Rotigotine—Headache—Topotecan—cervical cancer	0.00129	0.0154	CcSEcCtD
Rotigotine—DRD4—Signaling Pathways—WNT5A—cervical cancer	0.00127	0.00138	CbGpPWpGaD
Rotigotine—Nausea—Topotecan—cervical cancer	0.00122	0.0146	CcSEcCtD
Rotigotine—DRD5—Signaling Pathways—NOTCH2—cervical cancer	0.0012	0.00131	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKAP13—cervical cancer	0.00118	0.00128	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—WNT5A—cervical cancer	0.00114	0.00124	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—WNT2—cervical cancer	0.00114	0.00124	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.00114	0.00124	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—WNT5A—cervical cancer	0.00112	0.00123	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.00102	0.00111	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—WNT5A—cervical cancer	0.00102	0.00111	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.000997	0.00109	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HES1—cervical cancer	0.000987	0.00108	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.00098	0.00107	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NOTCH2—cervical cancer	0.000889	0.00097	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TERT—cervical cancer	0.000865	0.000944	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000861	0.000939	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NOTCH2—cervical cancer	0.0008	0.000873	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—FGFR3—cervical cancer	0.000794	0.000866	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NOTCH2—cervical cancer	0.00079	0.000862	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CA9—cervical cancer	0.000748	0.000816	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—NOTCH1—cervical cancer	0.000745	0.000813	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HES1—cervical cancer	0.000729	0.000795	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	0.000713	0.000778	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.000688	0.000751	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—EGFR—cervical cancer	0.000664	0.000725	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HES1—cervical cancer	0.000656	0.000716	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HES1—cervical cancer	0.000647	0.000706	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TERT—cervical cancer	0.000639	0.000697	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CA9—cervical cancer	0.000634	0.000692	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000604	0.000659	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—FGFR3—cervical cancer	0.000586	0.000639	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HES1—cervical cancer	0.000584	0.000638	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—TP53—cervical cancer	0.000575	0.000628	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TERT—cervical cancer	0.000575	0.000627	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TERT—cervical cancer	0.000567	0.000619	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HES1—cervical cancer	0.000564	0.000616	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MTOR—cervical cancer	0.000559	0.00061	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NOTCH1—cervical cancer	0.00055	0.0006	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—FGFR3—cervical cancer	0.000528	0.000576	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—FGFR3—cervical cancer	0.000521	0.000568	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CASP3—cervical cancer	0.000514	0.000561	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TERT—cervical cancer	0.000512	0.000559	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HES1—cervical cancer	0.000495	0.000541	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NOTCH1—cervical cancer	0.000495	0.00054	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CTNNB1—cervical cancer	0.000495	0.00054	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TERT—cervical cancer	0.000494	0.000539	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—EGFR—cervical cancer	0.00049	0.000535	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CA9—cervical cancer	0.000489	0.000534	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NOTCH1—cervical cancer	0.000489	0.000533	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	0.00047	0.000513	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—FGFR3—cervical cancer	0.000454	0.000495	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—EGFR—cervical cancer	0.000441	0.000482	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	0.000441	0.000481	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—EGFR—cervical cancer	0.000435	0.000475	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TERT—cervical cancer	0.000434	0.000474	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—STAT3—cervical cancer	0.000432	0.000471	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	0.000426	0.000465	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MTOR—cervical cancer	0.000412	0.00045	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—FGFR3—cervical cancer	0.000398	0.000435	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	0.000393	0.000429	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—EGFR—cervical cancer	0.000392	0.000428	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—EGFR—cervical cancer	0.000379	0.000414	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CASP3—cervical cancer	0.000379	0.000414	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NOTCH1—cervical cancer	0.000374	0.000408	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MTOR—cervical cancer	0.000371	0.000405	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MTOR—cervical cancer	0.000366	0.0004	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CTNNB1—cervical cancer	0.000366	0.000399	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CASP3—cervical cancer	0.000341	0.000372	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CASP3—cervical cancer	0.000337	0.000368	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—EGFR—cervical cancer	0.000333	0.000364	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MTOR—cervical cancer	0.000331	0.000361	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—cervical cancer	0.000329	0.000359	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CTNNB1—cervical cancer	0.000329	0.000359	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CTNNB1—cervical cancer	0.000325	0.000354	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MTOR—cervical cancer	0.000319	0.000348	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—STAT3—cervical cancer	0.000319	0.000348	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CASP3—cervical cancer	0.000304	0.000332	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—MTHFR—cervical cancer	0.000304	0.000331	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CASP3—cervical cancer	0.000294	0.00032	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	0.000293	0.00032	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EGFR—cervical cancer	0.00029	0.000316	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—STAT3—cervical cancer	0.000287	0.000313	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—STAT3—cervical cancer	0.000283	0.000309	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	0.000283	0.000309	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MTOR—cervical cancer	0.00028	0.000306	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EGFR—cervical cancer	0.000261	0.000284	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CASP3—cervical cancer	0.000258	0.000281	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—MTHFR—cervical cancer	0.000257	0.000281	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EGFR—cervical cancer	0.000257	0.000281	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—STAT3—cervical cancer	0.000255	0.000279	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CTNNB1—cervical cancer	0.000248	0.000271	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—STAT3—cervical cancer	0.000247	0.000269	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—cervical cancer	0.000243	0.000265	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EGFR—cervical cancer	0.000232	0.000253	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EGFR—cervical cancer	0.000224	0.000245	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—cervical cancer	0.000219	0.000239	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—STAT3—cervical cancer	0.000217	0.000236	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—cervical cancer	0.000216	0.000236	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—MTHFR—cervical cancer	0.000199	0.000217	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EGFR—cervical cancer	0.000197	0.000215	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—cervical cancer	0.000195	0.000213	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—cervical cancer	0.000188	0.000205	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—cervical cancer	0.000165	0.00018	CbGpPWpGaD
